According to Editas Medicine 's latest financial reports the company's total assets are $0.49 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.49 B | -2.95% |
2022-12-31 | $0.51 B | -24.08% |
2021-12-31 | $0.67 B | 18.32% |
2020-12-31 | $0.57 B | 12.52% |
2019-12-31 | $0.50 B | 21.05% |
2018-12-31 | $0.42 B | 12.63% |
2017-12-31 | $0.37 B | 62.87% |
2016-12-31 | $0.22 B | 53.44% |
2015-12-31 | $0.14 B | 1125.49% |
2014-12-31 | $12.18 M | 391.25% |
2013-12-31 | $2.48 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $8.88 M | -98.22% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.20 B | -59.48% | ๐ฌ๐ง UK |
Novavax NVAX | $1.79 B | 260.11% | ๐บ๐ธ USA |
Novocure
NVCR | $1.14 B | 129.61% | Jersey |